CAVERJECT STERILE POWDER - PWS 23.2MCG/VIAL 20 MCG
ALPROSTADIL : 20 MCG · DIN 02215187 · PFIZER CANADA ULC
Health Canada status: MARKETED
What is CAVERJECT STERILE POWDER - PWS 23.2MCG/VIAL?
CAVERJECT STERILE POWDER - PWS 23.2MCG/VIAL 20 MCG contains ALPROSTADIL : 20 MCG. It is listed in the Health Canada Drug Product Database under DIN 02215187, held by PFIZER CANADA ULC, supplied as POWDER FOR SOLUTION for INTRACAVERNOSAL administration. Health Canada currently lists it as marketed, status dated 09-Nov-2005. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
What is CAVERJECT STERILE POWDER - PWS 23.2MCG/VIAL used for?
CAVERJECT STERILE POWDER (alprostadil) is indicated for: the intracavernosal treatment of erectile dysfunction due to neurogenic, vasculogenic, psychogenic, or mixed etiology. Intracavernosal CAVERJECT STERILE POWDER may also be useful as an adjunct to diagnostic tests in the diagnosis of erectile dysfunction.
Authorized indication as written in the Health Canada product monograph. For healthcare professionals and licensed purchasers; this is not medical advice.
What else is CAVERJECT STERILE POWDER - PWS 23.2MCG/VIAL called?
The same molecule, ALPROSTADIL, is registered under other names elsewhere. Buyers and prescribers searching from outside Canada — or working from a foreign prescription or tender document — often know it by one of these:
| Name | Script | Registered in |
|---|---|---|
| Bondil | Latin | Norway |
| CAVERJECT | Latin | Brazil, Morocco |
| Caverject Impulse | Latin | Australia |
| Prostin VR | Latin | Bahrain, South Africa |
| Prostivas | Latin | Iceland, Norway |
| Vitaros | Latin | Norway |
| Alprostan | Latin | Slovakia |
| Prostavasin | Latin | Slovakia |
| PROSTIN VR AMP | Latin | Saudi Arabia |
Names are taken from national medicine registers and published price lists. A product registered abroad is not authorized for sale in Canada unless it holds its own DIN; import is possible only through the routes Health Canada permits.
Product details and regulatory record
| DIN | 02215187 |
|---|---|
| Brand name | CAVERJECT STERILE POWDER - PWS 23.2MCG/VIAL |
| Generic / active ingredient | ALPROSTADIL : 20 MCG |
| Manufacturer | PFIZER CANADA ULC |
| Strength | 20 MCG |
| Dosage form | POWDER FOR SOLUTION |
| Route of administration | INTRACAVERNOSAL |
| Schedule | Prescription |
| ATC code | G04BE01 ALPROSTADIL |
| AHFS class | 24:12.92 |
| Biosimilar | No |
| Health Canada status | MARKETED |
| Status date | 09-Nov-2005 |
| Original market date | 1997-09-24 00:00:00 |
How is this product identified?
Purchase orders, customs paperwork and tender documents each ask for a different identifier, and a DIN written without its leading zeros is the single most common reason an order line fails to match. Every form Nexara accepts for this product is listed here.
| DIN (8-digit, as used in Nexara ordering) | 02215187 |
|---|---|
| DIN (unpadded, as printed on some documents) | 2215187 |
| Brand name | CAVERJECT STERILE POWDER - PWS 23.2MCG/VIAL |
| Active ingredient / INN | ALPROSTADIL : 20 MCG |
| ATC code | G04BE01 |
| ATC anatomical main group | G — Genito-urinary system and sex hormones |
| ATC therapeutic subgroup | G04 |
| AHFS class | 24:12.92 |
| Health Canada schedule | Prescription |
| Biosimilar biologic | No |
| Market authorization holder | PFIZER CANADA ULC |
How is it stored and handled?
null
How is it supplied?
Cartons containing 5 cases. Each case contains: a single dose vial of 20 mcg CAVERJECT STERILE POWDER sterile powder, 1 mL pre-filled syringe of BWFI diluent, a 27-gauge, 0.5-inch needle, 2 alcohol swabs and Patient Administration Leaflet.
Which pack is which?
| Strength on the label | 20 MCG |
|---|---|
| Dosage form | POWDER FOR SOLUTION |
| Route | INTRACAVERNOSAL |
| Packaging as described in the monograph | Cartons containing 5 cases. Each case contains: a single dose vial of 20 mcg CAVERJECT STERILE POWDER sterile powder, 1 mL pre-filled syringe of BWFI diluent, a 27-gauge, 0.5-inch needle, 2 alcohol swabs and Patient Administration Leaflet. |
| Storage | null |
One DIN can cover more than one pack size, and the pack — not the DIN — is what gets priced, shipped and invoiced. Before an order line is unambiguous Nexara needs the strength, the pack size and the presentation.
What can be used instead?
Other Canadian products sharing ATC code G04BE01 ALPROSTADIL. 2 of 10 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.
| Product | Strength | Form | Manufacturer | Health Canada status | DIN |
|---|---|---|---|---|---|
| CAVERJECT STERILE POWDER | 20 MCG | LIQUID ; KIT ; POWDER FOR SOLUTION | PFIZER CANADA ULC | MARKETED | DIN 02215756 |
| CAVERJECT STERILE POWDER - KIT 11.9MCG /VIAL | 99.1 % | POWDER FOR SOLUTION ; KIT ; LIQUID | PFIZER CANADA ULC | CANCELLED POST MARKET | DIN 02215748 |
| CAVERJECT STERILE POWDER - PWS 11.9MCG/VIAL | 11.9 MCG | POWDER FOR SOLUTION | PFIZER CANADA ULC | CANCELLED POST MARKET | DIN 02215179 |
| MUSE | 1000 MCG | SUPPOSITORY | ENDO OPERATIONS LTD. | CANCELLED POST MARKET | DIN 02238595 |
| MUSE | 125 MCG | SUPPOSITORY | PALADIN PHARMA INC. | CANCELLED PRE MARKET | DIN 02238592 |
| MUSE | 250 MCG | SUPPOSITORY | ENDO OPERATIONS LTD. | CANCELLED POST MARKET | DIN 02238593 |
| MUSE | 500 MCG | SUPPOSITORY | ENDO OPERATIONS LTD. | CANCELLED POST MARKET | DIN 02238594 |
| VITAROS | 220 MCG / 100 MG | CREAM | BGP PHARMA ULC | APPROVED | DIN 02359413 |
| VITAROS | 330 MCG / 100 MG | CREAM | BGP PHARMA ULC | APPROVED | DIN 02359421 |
Who else supplies ALPROSTADIL worldwide?
Nexara tracks national medicine registries and published price lists across multiple markets. ALPROSTADIL appears in 39 registered pack listings across 13 markets, published on 11 different national price bases. Where a Canadian route is closed, that is where an alternative route of supply starts — subject to the import rules in both countries.
Registered listings are not stock. Ask us to confirm what can actually be sourced for your order.
How much does ALPROSTADIL cost around the world?
ALPROSTADIL is listed on 15 national price registers Nexara tracks, across 42 pack listings published on 14 different price bases. What each country publishes is set out below.
| Market | What that country publishes | Brands listed | Pack listings | As of |
|---|---|---|---|---|
| Norway | max AUP (pharmacy retail) | 3 | 7 | 07 Sep 2026 |
| Spain | PVP con IVA (public price) | 6 | 6 | 05 Sep 2026 |
| Greece | producer price (ex-factory) | 3 | 3 | 03 Sep 2026 |
| Italy | ex-factory (classe H) | 3 | 3 | 02 Sep 2026 |
| Romania | max producer price | 3 | 3 | 03 Sep 2026 |
| Saudi Arabia | public | 3 | 3 | 01 Sep 2026 |
| Slovakia | categorised final price | 3 | 3 | 02 Sep 2026 |
| Australia | ex-manufacturer | 1 | 2 | 08 Sep 2026 |
| Brazil | preco fabrica (ex-factory ceiling) | 1 | 2 | 02 Sep 2026 |
| Hungary | producer price (ex-factory) | 2 | 2 | 03 Sep 2026 |
| Morocco | PPV (public price) | 1 | 2 | 05 Sep 2026 |
| South Africa | single exit price | 2 | 2 | 01 Sep 2026 |
| United Arab Emirates | public | 1 | 1 | 31 Aug 2026 |
| Bahrain | retail (max) | 1 | 1 | 01 Sep 2026 |
| Iceland | max wholesale | 1 | 1 | 02 Sep 2026 |
| Italy | prezzo al pubblico (classe A) | 1 | 1 | 02 Sep 2026 |
Why there are no figures here. These bases are not comparable. A Brazilian ex-factory ceiling, a Belgian pharmacy public price and a Japanese reimbursement rate answer three different questions, and none of them is what a product lands in Canada for. Putting them side by side would mislead in both directions, so Nexara publishes where a molecule is listed and on what basis, and quotes the delivered Canadian price per order.
How can I get it?
Nexara Health supplies this product to licensed Canadian buyers — pharmacies, hospitals, clinics, licensed distributors, and clinical trial sponsors or their CROs. We confirm stock, pack size, expiry and pricing at the time of quotation. If the product is on backorder or in shortage, we identify equivalent alternatives and import options where permitted.
Request a quote for CAVERJECT STERILE POWDER - PWS 23.2MCG/VIAL
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.